TerminatedPhase 2

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

NCT03919162

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Barrow Neurological Institute

Phoenix, Arizona, United States

+21 additional locations

Save this trial

Barrow Neurological InstitutePhoenix, Arizona, United States
Banner Sun Health Research InstituteSun City, Arizona, United States
The Neuron ClinicChula Vista, California, United States
University of CaliforniaIrvine, California, United States
UCSD Alzheimer's Disease Research CenterLa Jolla, California, United States
Cedars-Sinai CenterLos Angeles, California, United States
PCND NeurologyPoway, California, United States
Georgetown University Medical CenterWashington D.C., District of Columbia, United States
USF Health Byrd Alzheimer's Center and Research InstituteTampa, Florida, United States
Emory UniversityAtlanta, Georgia, United States
Northwestern University Feinberg School of MedicineChicago, Illinois, United States
The University of Iowa Carver College of MedicineIowa City, Iowa, United States
The University of Kentucky Sanders-Brown Center on AgingLexington, Kentucky, United States
Northern Light Acadia HospitalBangor, Maine, United States
NYU Langone Health Tisch HospitalNew York, New York, United States
SUNY Upstate Medical UniversitySyracuse, New York, United States
Ohio State UniversityColumbus, Ohio, United States
OHSU Neurology ClinicPortland, Oregon, United States
Abington Neurological AssociatesAbington, Pennsylvania, United States
Rhode Island HospitalProvidence, Rhode Island, United States
Lowcountry Center for Veterans Research (LCVR)Charleston, South Carolina, United States
UT Health San AntonioSan Antonio, Texas, United States